# | SuperPathway Name | Genes Count | Relevance Score | |||||
---|---|---|---|---|---|---|---|---|
1 | Imatinib-resistant KIT mutants | 1 | 1.408 | |||||
|
||||||||
2 | Imatinib and chronic myeloid leukemia | 20 | 1.408 | |||||
|
||||||||
3 | Sorafenib-resistant PDGFR mutants | 1 | 0.679 | |||||
|
||||||||
4 | Ponatinib Pathway, Pharmacokinetics/Pharmacodynamics | 34 | 0.679 | |||||
|